Company & Sponsor Intelligence
Rhode Island Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting0
Completed4
Countries1
Therapeutic footprint
adhdalzheimersautismdepressionepilepsy
Indexed studies
NCT02591446Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT02290899Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder
adhd · United StatesCOMPLETED
adhd · United StatesCOMPLETED
NCT00835627Treatment Trial for Psychogenic Nonepileptic Seizures
epilepsy · United StatesPHASE4
epilepsy · United StatesPHASE4
NCT01841905Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
alzheimers · United StatesUNKNOWN
alzheimers · United StatesUNKNOWN
NCT02053649Integrated Chronotherapy for Perinatal Depression
depression · United StatesNA
depression · United StatesNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →